Sandoz Group P/FCF

Que fait Sandoz Group ? Sandoz Group AG is a pharmaceutical company headquartered in Rotkreuz, Switzerland. It operates in the healthcare sector, specifically within the pharmaceuticals industry. The company went public on October 4, 2023, with its ticker listed as SDZ.SW and ISIN CH1243598427. Sandoz Group AG focuses on two primary business areas: Generics and Biosimilars. The Generics division develops, manufactures, and markets active ingredients and finished dosage forms of small molecule pharmaceuticals, as well as anti-infective finished dosage forms and active pharmaceutical ingredients. The Biosimilars division develops, manufactures, and markets protein-based and other biological products that are similar to already approved biological medicines. The company's product portfolio spans multiple therapeutic areas, including cardiovascular, central nervous system, oncology, anti-infectives, pain, and respiratory conditions. Sandoz Group AG serves customers globally, providing pharmaceutical solutions across various medical fields. The company is based in Switzerland and operates within the pharmaceuticals industry, with its headquarters located in Rotkreuz. It is active in the healthcare technology industry, though specific details about its technology focus are not provided. The company's operations are centered around the development and distribution of generic and biosimilar medications to meet global healthcare needs. Sandoz Group est l'une des entreprises les plus populaires sur Eulerpool.